Collaboration Allows Genprex to Accelerate Manufacturing Processes for IND-Enabling Preclinical Studies and Future Clinical Trials AUSTIN, Texas — (Aug.18, 2026) — Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ:...
Collaboration Advances Biomarker-Driven Patient Selection and Precision Medicine in Oncology Validation Studies Aim to Optimize Clinical Trial Patient Selection Criteria AUSTIN, Texas — (Aug. 3, 2026) — Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ:...
Patent Covers Acclaim-3 Clinical Trials Combining REQORSA Gene Therapy with Genentech, Inc.’s Tecentriq® AUSTIN, Texas — (June 22, 2026) — Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ:...
The BIO International Convention Brings Together More Than 20,000 Biotech Industry Leaders From Around The World AUSTIN, Texas — (June 17, 2026) — Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ:...